Infliximab to Treat Chronic Noninfectious Uveitis in Children: Retrospective Case Series with Long-term Follow-up

American Journal of Ophthalmology

Volumn 144, Issue 6, 2007, Pages

  Ardoin, Stacy P ^a   Kredich, Deborah ^a   Rabinovich, Egla ^a   Schanberg, Laura E ^a   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; EYE INFLAMMATION; FEMALE; HUMAN; LONG TERM CARE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; UVEITIS; VISUAL ACUITY;

EID: 36248986279     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.08.018     Document Type: Article

References (22)

1. de Boer J., Wulffraat N., and Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 87 (2003) 879-884
2. Olson N.Y., Lindsley C.B., and Godfrey W.A. Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child 142 (1988) 1289-1292
3. Makela A.L. Naproxen in the treatment of juvenile rheumatoid arthritis. Scand J Rheumatol 6 (1977) 193-205
4. Weiss A.H., Wallace C.A., and Sherry D.D. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 133 (1998) 266-268
5. Foeldvari I., and Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32 (2005) 362-365
6. Kilmartin D.J., Forrester J.V., and Dick A.D. Cyclosporine A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 82 (1998) 737-742
7. Thorne J.E., Jabs D.A., Qazi F.A., Nguyen Q.D., Kempen J.H., and Dunn J.P. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112 (2005) 1472-1477
8. Reiff A., Takei S., Sadeghi S., et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 44 (2001) 1411-1415
9. Reiff A. Long-term outcome of etanercept therapy in children with treatment-refractory uveitis. Arthritis Rheum 48 (2003) 2079-2080
10. Smith J.A., Thompson D.J., Whitcup S.M., et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53 (2005) 18-23
11. Biester S., Deuter C., Michels H., et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91 (2007) 274-276
12. Vazquez-Cobian L.B., Flynn T., and Lehman T.J. Adalimumab therapy for childhood uveitis. J Pediatr 149 (2006) 572-575
13. Kahn P., Weiss M., Imundo L.F., and Levy D.M. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 113 (2006) 864.e1-864.e2
14. Rajaraman R.T., Kimura Y., Li S., Haines K., and Chu D.S. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 113 (2006) 308-314
15. Richards J.C., Tay-Kearney M., Murrah K., and Manners P. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Experiment Ophthalmol 33 (2005) 461-468
16. Saurenmann R.K., Levin A.V., Rose J.B., et al. Tumor necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) 45 (2006) 982-989
17. Hogan M.J., Kimura S.J., and Thygeson P. Signs and symptoms of uveitis. Am J Ophthalmol 47 (1959) 155-170
18. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T., and Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of First International Workshop. Am J Ophthalmol 140 (2005) 509-516
19. Maini R., St Clair E.W., Breedveld F., et al. Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 354 (1999) 1932-1939
20. Hanauer S.B., Feagan B.F., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 359 (2002) 1541-1549
21. Mpofu S., Fatima F., and Moots R.J. Anti-TNF-alpha therapies: they are all the same (aren't they?). Rheumatology (Oxford) 44 (2005) 271-273
22. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., and Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 (2006) 2275-2285